HF

Helen Fisher

Non-Executive Director at Paradigm Biopharma

Helen is CEO and managing director of Cio Capital Impact Fund (BCIF) and Non – Executive Director (NED) and Chair of the Audit and Risk Committee of Calic Limited (ASX: CXL), a company with a platform technology with applications in climate change, water management, biotech, and pharmaceutical areas. Prior to establishing BCIF, Helen was a partner of Deloitte and led Deloitte’s life science practice in Australia for 5 years, having had many years’ experience in the life sciences and health care sector.

Timeline

  • Non-Executive Director

    Current role